Evidence map›Paper›PMID 40520096›Full record

ArticleiScience2025

A triple serine motif in the intracellular domain of SorCS2 impacts its cellular signaling.

Anders Dalby, Mathias Kaas, Lars Meinertz Byg, Signe Bundgaard Christiansen, Christian M Longworth, Simon Bøggild Hansen, Per Qvist, Jens R Nyengaard, Peder Madsen, Simon Mølgaard and 1 more

Abstract read
In one paragraph

Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Anders DalbyDepartment of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.
Mathias KaasDepartment of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.
Lars Meinertz BygDepartment of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.
Signe Bundgaard ChristiansenDepartment of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.
Christian M LongworthDepartment of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.
Simon Bøggild HansenDepartment of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.
Per QvistDepartment of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.
Jens R NyengaardCore Center for Molecular Morphology, Section for Stereology and Microscopy, Department of Clinical Medicine, Aarhus University, 8200 Aarhus, Denmark.
Peder MadsenDepartment of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.
Simon MølgaardDepartment of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.
Simon GlerupDepartment of Biomedicine, Aarhus University, 8000 Aarhus, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Vps10p-domain receptors SorCS1-3 have been repeatedly associated with the development of neurological and psychiatric disorders. They have emerged as key regulators of synaptic activity and neurotrophic signaling, but the underlying molecular mechanism remains poorly understood. Here we report that the SorCS2 intracellular domain (ICD) contains a triple serine motif that potentially functions as a signaling switch to induce intracellular signaling in hippocampal neurons. We show, that serine to alanine substitution in this motif renders neurons less responsive to BDNF, whereas phosphomimetic mutations induce neurotrophic effects independently of the SorCS2 extracellular domain (ECD) and BDNF. Hence, we develop triple serine motif-based cell-penetrating peptides that modulate distinct intracellular signaling, partially overlapping with the BDNF pathway, ultimately activating the transcription factor CREB. Taken together, we provide insights into SorCS2 mediated neurotrophic signaling and use this knowledge to develop pharmacologically active molecules.

Indexed as

Molecular biologyMolecular neuroscience

Identifiers

PMID40520096
PMCPMC12164027

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.